Bioassay Blog Landing Page - Quantics Biostatistics

The Bursa – Yellowlees Method for Interpolation 5

The Bursa-Yellowlees Method for Interpolation Analysis

Interpolation analysis is used to find the concentration of a substance in a sample. For biologics, this is often used in ELISA analyses and other bioanalytic analyses. This blog... read more →

How to Set Suitability Criteria for Relative Potency Bioassays

In our last blog we discussed the purpose of system suitability tests and sample suitability tests and gave some examples of each. However, we did not explain how to... read more →

15th February 2019
Francis Bursa
No Comments
Bioassay

Understanding System and Sample Suitability Tests for Bioassay.

Suitability tests for bioassay are often confusing. In this blog, we discuss the two types of suitability tests: System suitability tests and Sample suitability tests. The blog is deliberately simplistic... read more →

31st August 2018
Francis Bursa
No Comments
Bioassay

Reduce animal use and improve the precision of your LD50 and vaccine challenge assays

LD50 assays and challenge assays both measure the time to an event, often death, for each animal. However the standard statistical approach to the analysis of the data treats the... read more →

How to Combine Relative Potencies for Bioassay

Welcome to our blog on combining relative potencies. In this blog, we’ll review the methods recommended by the United States Pharmacopeia (USP) and European Pharmacopoeia (PhEur) for combining relative potencies,... read more →

20th February 2018
Francis Bursa
No Comments
Bioassay

Can we consign “The Edge Effect” to history?

We can waste about 40% of multi-well plates to avoid biasing the relative potency (RP) due to “the edge effect”. Quantics recently used a Latin square design to support a... read more →

15th December 2017
Ann Yellowlees
No Comments
Bioassay

When and How Should I Transform my Response Data?

Our clients sometimes tell us that they don’t want to use response transformations since it feels like an unwarranted manipulation of the data. However, there is little point in avoiding... read more →

29th August 2017
Francis Bursa
No Comments
Bioassay

Non-parallelism and Biosimilars

Many of our readers will be familiar with our paper “Parallelism in Practice” (PDA Journal of Pharmaceutical Science and Technology, 2015) and how we examined the common methods used for... read more →

Inadvertent Consequences of Following a Guideline – European Pharmacopeia 9.2 section 5.3

Following the EurPh recommendations mixes up system and sample suitability and can lead to undesirable results. Assays failing when they should pass Assays passing when they should fail We recommend... read more →

Complications of fitting 4PL and 5PL models to bioassay data

Welcome to our fourth bioassay blog from Quantics Biostatistics. In our previous blog we discussed the 4 parameter logistic (4PL) model. This is a symmetrical S-shaped curve with the equation... read more →

Reducing bioassay parallelism failures through better LOQ methodologies

As a slight change to our regular bioassay blog series where we last looked at the choice of statistical model when dealing with continuous response data. We thought we would... read more →

25th October 2016
Francis Bursa
No Comments
Bioassay

Choosing a statistical model: Continuous response data

In the last blog we discussed the definition of relative potency and how it relates to the concepts of biological similarity and thus the need for parallelism between the reference... read more →

24th August 2016
Francis Bursa
1 Comment
Bioassay

What is Relative Potency?

Relative potency is a term used in bioassay to refer to the ability of a test sample, of unknown potency, to produce the desired response compared to a reference sample,... read more →

Discussions and insights

on statistical issues in life sciences

Bioassay Blog